Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
F.C.P.S., M.B.B.S.
Diabetologist
M.C.P.S, D.Diabetologist, D.Diabetologist (UK)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.PHIL (Diabetes Mellitus), Ph.D (Diabetes Mellitus)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.PHIL (Diabetes Mellitus), Ph.D (Diabetes Mellitus)
Consultant Physician
M.B.B.S., F.C.P.S., MACP ( USA), FPSIM (PAK), RCP London (UK)
Consultant Physician
M.B.B.S., F.C.P.S., MACP ( USA), FPSIM (PAK), RCP London (UK)
Diabetologist
M.B.B.S, MSc (Diabetes/Endocrinology)
Consultant Physician
M.B.B.S., F.C.P.S.
Consultant Physician
M.B.B.S., M.R.C.P
Consultant Physician
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., M.D. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures